BMC Chemistry · 2013 · 28 citations · 37 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryStructure-activity RelationshipsMedicinal PlantsStructure-activity Relationship AnalysisMedicinal Chemistry ApplicationsMedicinal Heterocycles
BACKGROUND: Coumarin and its derivatives are biologically very active. It was found that the enhanced activities are dependent on the coumarin nucleus. Biological significance of these compounds include anti-bacterial, anti-thrombotic and vasodilatory, anti-mutagenic, lipoxygenase and cyclooxygenase inhibition, scavenging of reactive oxygen species, and anti-tumourigenic. Our interest in medicinal chemistry of dicoumarol compounds have been developed by keeping in view the importance of coumarins along with its derivatives in medicinal chemistry. All the synthesized compounds were fully characterized by spectroscopic and analytical techniques and were screened for antimicrobial and U2OS bone cancer activities. RESULTS: 4-hydroxycoumarin was derivatized by condensing with different aldehydes yielding the dicoumarol and translactonized products. Elemental analyses, ESI(+,-) MS, 1H and 13C{1H}-NMR, infrared spectroscopy and conductance studies were used to characterize the synthesized compounds which revealed the dicoumarol and dichromone structures for the compounds. The compounds were screened against U2OS cancerous cells and pathogenic micro organisms. The compounds with intermolecular H-bonding were found more active revealing a possible relationship among hydrogen bonding, cytotoxicity and antimicrobial activities. CONCLUSION: Coumarin based drugs can be designed for the possible treatment of U2OS leukemia.
37
Antidiabetic vanadium(IV) and zinc(II) complexes
Hiromu Sakurai, Yoshitane Kojima, Yutaka Yoshikawa et al. · Coordination Chemistry Reviews · 2002 · 535 citations
Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin
Chau-Jong Wang, Yu-Jin Hsieh, Chia-Yih Chu et al. · Cancer Letters · 2002 · 281 citations
Screening of potential chemopreventive agents using biochemical markers of carcinogenesis.
Sheela Sharma, Jill D. Stutzman, Gary J. Kelloff et al. · PubMed · 1994 · 265 citations
Medicine, Pharmacology, Toxicology +13